Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2007
Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues
P Fumoleau, B Coudert, N Isambert, et al.
International Journal of Oncology
|
June 28, 2014
Emerging targets to monitor and overcome docetaxel resistance in castration resistant prostate cancer (review)
L Magadoux, N Isambert, S Plenchette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2009
Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy
N Penel, A Italiano, N Isambert, et al.
Cancer
|
August 22, 2000
Trends in incidence and management of gallbladder carcinoma: a population-based study in France
S Manfredi, A M Benhamiche, N Isambert, et al.
European Journal of Gastroenterology & Hepatology
|
February 3, 2000
Cancer of the ampulla of Vater: results of a 20-year population-based study
A M Benhamiche, J L Jouve, S Manfredi, et al.
Cancer Chemotherapy and Pharmacology
|
November 3, 2011
A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes
M Campone, N Isambert, E Bourbouloux, et al.
Investigational New Drugs
|
September 6, 2013
Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)
T Valentin, C Fournier, N Penel, et al.
Cancer Chemotherapy and Pharmacology
|
October 13, 2006
Phase I dose-escalation study of a novel antitumor agent, SR271425, administered intravenously in split doses (d1-d2-d3) in patients with refractory solid tumors
M Campone, N Isambert, E Bourbouloux, et al.
Leukemia
|
June 24, 2000
Increase therapy-related leukemia secondary to breast cancer
P M Carli, C Sgro, N Parchin-Geneste, et al.
Annales De Medecine Interne
|
August 3, 2000
[Malignant paraganglioma of the uterus]
N Isambert, P Gros, P Commegeille, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2007
Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues
P Fumoleau, B Coudert, N Isambert, et al.
International Journal of Oncology
|
June 28, 2014
Emerging targets to monitor and overcome docetaxel resistance in castration resistant prostate cancer (review)
L Magadoux, N Isambert, S Plenchette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2009
Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy
N Penel, A Italiano, N Isambert, et al.
Cancer
|
August 22, 2000
Trends in incidence and management of gallbladder carcinoma: a population-based study in France
S Manfredi, A M Benhamiche, N Isambert, et al.
European Journal of Gastroenterology & Hepatology
|
February 3, 2000
Cancer of the ampulla of Vater: results of a 20-year population-based study
A M Benhamiche, J L Jouve, S Manfredi, et al.
Cancer Chemotherapy and Pharmacology
|
November 3, 2011
A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes
M Campone, N Isambert, E Bourbouloux, et al.
Investigational New Drugs
|
September 6, 2013
Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)
T Valentin, C Fournier, N Penel, et al.
Cancer Chemotherapy and Pharmacology
|
October 13, 2006
Phase I dose-escalation study of a novel antitumor agent, SR271425, administered intravenously in split doses (d1-d2-d3) in patients with refractory solid tumors
M Campone, N Isambert, E Bourbouloux, et al.
Leukemia
|
June 24, 2000
Increase therapy-related leukemia secondary to breast cancer
P M Carli, C Sgro, N Parchin-Geneste, et al.
Annales De Medecine Interne
|
August 3, 2000
[Malignant paraganglioma of the uterus]
N Isambert, P Gros, P Commegeille, et al.
Page
of 6